Skip to main content

Day: May 30, 2022

Form 8.3 – [Ideagen plc – 27 05 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDEAGEN PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDEAGEN PLC AS AN ASSOCIATE OF THE...

Continue reading

Huazhu Group Limited Reports First Quarter of 2022 Unaudited Financial Results

A total of 7,988 hotels or 764,859 hotel rooms in operation as of March 31, 2022. Hotel turnover1 increased 16.4% year-over-year to RMB9.5 billion for the first quarter of 2022. Excluding Steigenberger Hotels AG and its subsidiaries (“DH”, or “Legacy-DH”), hotel turnover increased 11.4% year-over-year for the first quarter. Revenue increased 15.2% year-over-year to RMB2.7 billion (US$423 million)2 for the first quarter of 2022, in line with revenue guidance previously announced of 11% to 15% compared to the first quarter of 2021. Revenue from Legacy-Huazhu segment for the first quarter of 2022 increased 4.6% year-over-year, in line with revenue guidance previously announced of 1% to 5%. Net loss attributable to Huazhu Group Limited was RMB630 million (US$99 million) for the first quarter of 2022, compared with RMB248 million for the first...

Continue reading

Form 8.3 – [CareTech Holdings plc – 27 05 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Ultra Lithium Provides an Update on Drilling at the Laguna Verde Brine Lithium Project in Argentina

VANCOUVER, British Columbia, May 30, 2022 (GLOBE NEWSWIRE) — Ultra Lithium Inc. (TSX-V: ULT) (“Ultra Lithium” or “the Company”) is pleased to provide an update on the drilling work at its 100% owned Laguna Verde brine lithium project in Catamarca Province, Argentina. Drill hole LV22-01 has been drilled to a depth of 210 m with an initial diameter of 9 7/8 inches to carry out geophysical studies. Later, the drill hole will be widened to 12 inches for well development, brine sampling and pumping testwork to check brine aquifer potential for future development. The geophysical study of the well indicated the presence of a continuous brine aquifer comprising of mainly clastic sediments from 13.9 meters to 205 m depth with a marked hydrothermal presence towards the deeper section. The aquifer is still open at depth. Downhole Geophysical...

Continue reading

Small Pharma To Present at the Jefferies Healthcare Conference in New York City on June 10, 2022

LONDON, May 30, 2022 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions, announces that Peter Rands, Chief Executive Officer, and Dr. Carol Routledge, Chief Medical and Scientific Officer, will present at the Jefferies Healthcare Conference, which is being held from June 8-10 in New York City. Details for the presentation are as follows: Event: Jefferies Healthcare ConferenceDate: Friday, June 10 2022Time: 11:30AM ETWebcast: Click this link to register for the live presentation. The replay will be available for 90 days following the presentation. To schedule a one-on-one meeting with Small Pharma’s management team, please contact your assigned Jefferies representative. About...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – FIRSTGROUP PLC – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

Canadian North Resources Inc. Announces Financial Results for the First Quarter Ended March 31, 2022

Highlights: Ended the quarter with cash and cash equivalents of $17,517,909; Confirmed the high-grade nickel, copper, palladium and platinum mineralized zones at the Ferguson Lake Project; Carrying out the resource estimate in compliance with the NI43-101 Standards; Started drilling to expand the mineral resources; Strengthened the Technical Team TORONTO, May 30, 2022 (GLOBE NEWSWIRE) — Canadian North Resources Inc. (“the Company”, TSXV: CNRI) is pleased to report the financial results for the first quarter ended March 31, 2022. “During the past quarter, we have strengthened the technical Team and started the over $11-million exploration programs at our 100% owned Ferguson Lake Project,” said Dr. Kaihui Yang, the President & CEO. “We are carrying out our first resource estimate in compliance with the NI43-101 Standards as...

Continue reading

Questor Announces First Quarter Results

CALGARY, Alberta, May 30, 2022 (GLOBE NEWSWIRE) — Questor Technology Inc. (“Questor” or the “Company”) (TSX-V: QST) announced today its financial and operating results for the first quarter 2022.   Questor’s Unaudited Condensed Consolidated Financial Statements and Management’s Discussion and Analysis for the quarter ended March 31, 2022 are available on the Company’s website at www.questortech.com/investors and through SEDAR at www.sedar.com. Unless otherwise noted, all financial figures are presented in Canadian dollars, prepared in accordance with International Financial Reporting Standards and are unaudited for the three months ended March 31, 2022. FIRST QUARTER 2022 FINANCIAL RESULTSFor the three months ended March 31,   2022     2021  (Stated in CDN $, unaudited)    Revenue   2,587,707     1,548,391  Gross...

Continue reading

Talenom grows through an acquisition in Sweden

Talenom Plc, Insider information 30 May 2022 at 14:00 EEST Talenom grows through an acquisition in Sweden Talenom has agreed to acquire the accounting services of Swedish Mazars Sweden. The acquired business will be transferred to a separate limited company before the transaction takes effect. The acquisition strengthens Talenom’s position in southern Sweden in the Skåne county, Stockholm and Gothenburg, where it serves SMEs in the region. The acquired company will be transferred to Talenom on 1 September 2022. The final execution of the transaction is conditional on the fulfillment of the conditions of the transfer of assets prior to the transaction. The annual net sales of the acquired company are around SEK 55 million (approximately EUR 5.2 million, using the average 2021 SEK/EUR exchange rate 10.5) and EBITDA is estimated to...

Continue reading

Italian authorities have approved Systemair’s acquisition of SagiCofim S.p.A.

Press Release, May 30, 2022 Systemair (NASDAQ OMX Stockholm: SYSR) announced on April 7, 2022 the agreement to acquire all shares in the Italian company SagiCofim S.p.A. The purchase has now been approved by the Italian authorities and completion of the transaction is estimated within 10 working days. SagiCofim is a leading international supplier with extensive experience in air filtration and air distribution. The company’s production facility in Cernusco sul Naviglio, Milan, produces highly efficient air filters of HEPA and ULPA class. In Sondrio in the Valtellina Valley, the company owns 50% of EFFEBI SRL, which manufactures products for air distribution. The companies’ consolidated sales in 2021 amounted to approximately EUR 36 million with an EBITDA result of EUR 4.0 million. The companies have about 200 employees. Completion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.